FDA Memo Does Not Simplify 1st Amendment Considerations
On Jan. 18, 2017, just two days before a new administration was set to take over, the U.S. Food and Drug Administration issued a memorandum purporting to address First Amendment and...To view the full article, register now.
Already a subscriber? Click here to view full article